Skip to main content

Translational Bioinformatics and Systems Biology Approaches for Personalized Medicine

  • Protocol
  • First Online:
Systems Biology in Drug Discovery and Development

Part of the book series: Methods in Molecular Biology ((MIMB,volume 662))

Abstract

Systems biology and pharmacogenomics are emerging and promising fields that will provide a thorough understanding of diseases and enable personalized therapy. However, one of the most significant obstacles in the practice of personalized medicine is the translation of scientific discoveries into better therapeutic outcomes. Translational bioinformatics is a powerful method to bridge the gap between systems biology research and clinical practice. This goal can be achieved through providing integrative methods to enable predictive models for therapeutic responses. As a media between bench and bedside, translational bioinformatics has the mission to meet challenges in the development of personalized medicine. On the biomedical side, translational bioinformatics would enable the identification of biomarkers based on systemic analyses. It can improve the understanding of the correlations between genotypes and phenotypes. It would enable novel insights of interactions and interrelationships among different parts in a whole system. On the informatics side, methods based on data integration, data mining, and knowledge representation can provide decision support for both researchers and clinicians. Data integration is not only for better data access, but also for knowledge discovery. Decision support based on translational bioinformatics means better information and workflow management, efficient literature and resource retrieval, and communication improvement. These approaches are crucial for understanding diseases and applying personalized therapeutics at systems levels.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Protocol
USD 49.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Yan Q (2005) Pharmacogenomics and systems biology of membrane transporters. Mol Biotechnol 29:75–88

    Article  CAS  PubMed  Google Scholar 

  2. Meyer UA (2004) Pharmacogenetics – five decades of therapeutic lessons from genetic diversity. Nat Rev Genet 5:669–676

    Article  CAS  PubMed  Google Scholar 

  3. Madhavan S, Zenklusen JC et al (2009) Rembrandt: helping personalized medicine become a reality through integrative translational research. Mol Cancer Res 7:157–167

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  4. Wang X, Liu L, Fackenthal J et al (2009) Translational integrity and continuity: personalized biomedical data integration. J Biomed Inform 42:100–112

    Article  PubMed  PubMed Central  Google Scholar 

  5. Greenes RA (2003) Decision support at the point of care: challenges in knowledge representation, management, and patient-specific access. Adv Dent Res 17:69–73

    Article  CAS  PubMed  Google Scholar 

  6. Yan Q (2003) Bioinformatics and data integration in membrane transporter studies. Methods Mol Biol 227:37–60

    CAS  PubMed  Google Scholar 

  7. American Medical Informatics Association (AMIA). AMIA strategic plan. Available at: http://www.amia.org/inside/stratplan/. Accessed July 2009

  8. Suh KS, Remache YK, Patel JS et al (2009) Informatics-guided procurement of patient samples for biomarker discovery projects in cancer research. Cell Tissue Bank 10:43–48

    Article  PubMed  Google Scholar 

  9. Yan Q et al (2000) Preventing adverse drug events (ADEs): the role of computer information systems. Drug Inf J 34:1247–1260

    Google Scholar 

  10. Yan Q (2008) The integration of personalized and systems medicine: bioinformatics support for pharmacogenomics and drug discovery. Methods Mol Biol 448:1–19

    Article  CAS  PubMed  Google Scholar 

  11. Aich P, Babiuk LA et al (2009) Biomarkers for prediction of bovine respiratory disease outcome. OMICS 13:199–209

    Article  CAS  PubMed  Google Scholar 

  12. Wehling M (2008) Translational medicine: science or wishful thinking? J Transl Med 6:31

    Article  PubMed  PubMed Central  Google Scholar 

  13. Emerson JW, Dolled-Filhart M et al (2009) Quantitative assessment of tissue biomarkers and construction of a model to predict outcome in breast cancer using multiple imputation. Cancer Inform 7:29–40

    CAS  PubMed  PubMed Central  Google Scholar 

  14. Chia S, Senatore F et al (2008) Utility of cardiac biomarkers in predicting infarct size, left ventricular function, and clinical outcome after primary percutaneous coronary intervention for ST-segment elevation myocardial infarction. JACC Cardiovasc Interv 1:415–423

    Article  PubMed  Google Scholar 

  15. Khuseyinova N, Koenig W (2006) Biomarkers of outcome from cardiovascular disease. Curr Opin Crit Care 12:412–419

    Article  PubMed  Google Scholar 

  16. Welsh P, Barber M et al (2009) Associations of inflammatory and haemostatic biomarkers with poor outcome in acute ischaemic stroke. Cerebrovasc Dis 27:247–253

    Article  CAS  PubMed  Google Scholar 

  17. Knudsen LS, Klarlund M et al (2008) Biomarkers of inflammation in patients with unclassified polyarthritis and early rheumatoid arthritis. Relationship to disease activity and radiographic outcome. J Rheumatol 35:1277–1287

    CAS  PubMed  Google Scholar 

  18. Ozkisacik EA, Discigil B et al (2006) Effects of cyclosporin a on neurological outcome and serum biomarkers in the same setting of spinal cord ischemia model. Ann Vasc Surg 20:243–249

    Article  PubMed  Google Scholar 

  19. Hurks R, Peeters W et al (2009) Biobanks and the search for predictive biomarkers of local and systemic outcome in atherosclerotic disease. Thromb Haemost 101:48–54

    CAS  PubMed  Google Scholar 

  20. Radulovic D, Jelveh S et al (2004) Informatics platform for global proteomic profiling and biomarker discovery using liquid chromatography-tandem mass spectrometry. Mol Cell Proteomics 3:984–997

    Article  CAS  PubMed  Google Scholar 

  21. Camp RL, Dolled-Filhart M et al (2004) X-tile: a new bio-informatics tool for biomarker assessment and outcome-based cut-point optimization. Clin Cancer Res 10:7252–7259

    Article  CAS  PubMed  Google Scholar 

  22. Yan Q (2008) Pharmacogenomics in drug discovery and development. Preface. Methods Mol Biol 448:v–vii

    PubMed  Google Scholar 

  23. Peleg M, Tu S (2006) Decision support, knowledge representation and management in medicine. Yearb Med Inform, 72–80

    Google Scholar 

  24. Schreiber G, Akkermans H, Anjewierden A et al (2000) Knowledge engineering and management: the common KADS methodology. The MIT Press, Cambridge, MA

    Google Scholar 

  25. Yan Q (2010) Bioinformatics for transporter pharmacogenomics and systems biology: data integration and modeling with UML. Methods Mol Biol 637:23–45

    Article  CAS  PubMed  Google Scholar 

  26. Daemen A, Gevaert O, Ojeda F et al (2009) A kernel-based integration of genome-wide data for clinical decision support. Genome Med 1:39

    Article  PubMed  PubMed Central  Google Scholar 

  27. Brazhnik O, Jones JF (2007) Anatomy of data integration. J Biomed Inform 40:252–269

    Article  PubMed  PubMed Central  Google Scholar 

  28. Hwang D, Rust AG, Ramsey S et al (2005) A data integration methodology for systems biology. Proc Natl Acad Sci USA 102:17296–17301

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  29. http://magnet.systemsbiology.net/software/Pointillist/. Accessed June 2009

  30. Hucka M, Finney A, Bornstein BJ et al (2004) Evolving a lingua franca and associated software infrastructure for computational systems biology: the Systems Biology Markup Language (SBML) project. Syst Biol (Stevenage) 1:41–53

    Article  CAS  Google Scholar 

  31. Ruttenberg A, Clark T, Bug W et al (2007) Advancing translational research with the Semantic Web. BMC Bioinform 8(Suppl 3):S2

    Article  Google Scholar 

  32. Rassinoux AM (2008) Decision support, knowledge representation and management: structuring knowledge for better access. Findings from the yearbook 2008 section on decision support, knowledge representation and management. Yearb Med Inform 80–82

    Google Scholar 

  33. Moskovitch R, Martins SB, Behiri E et al (2007) A comparative evaluation of full-text, concept-based, and context-sensitive search. J Am Med Inform Assoc 14:164–174

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Qing Yan .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2010 Springer Science+Business Media, LLC

About this protocol

Cite this protocol

Yan, Q. (2010). Translational Bioinformatics and Systems Biology Approaches for Personalized Medicine. In: Yan, Q. (eds) Systems Biology in Drug Discovery and Development. Methods in Molecular Biology, vol 662. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-60761-800-3_8

Download citation

  • DOI: https://doi.org/10.1007/978-1-60761-800-3_8

  • Published:

  • Publisher Name: Humana Press, Totowa, NJ

  • Print ISBN: 978-1-60761-799-0

  • Online ISBN: 978-1-60761-800-3

  • eBook Packages: Springer Protocols

Publish with us

Policies and ethics